Correction to: Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1918
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Correction to: Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use ; volume:41 ; number:6 ; day:20 ; month:4 ; year:2021 ; pages:591 ; date:6.2021
Clinical drug investigation ; 41, Heft 6 (20.4.2021), 591, 6.2021
- Urheber
-
Hoy, Sheridan M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40261-021-01036-3
- URN
-
urn:nbn:de:101:1-2021100308190979499827
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hoy, Sheridan M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease
Correction to: Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease
Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use
Correction to: Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use
Effectiveness of Amikacin liposome inhalation suspension for refractory Mycobacterium avium complex pulmonary disease at 6 months post initiation
Qualitative Interviews Exploring Adverse Event Mitigation Strategies in Adults Receiving Amikacin Liposome Inhalation Suspension
Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment-Refractory Nontuberculous Mycobacterial Lung Disease
A comparative study of Mycobacterium avium subsp. avium and Mycobacterium avium subsp. hominissuisin experimentally infected pigs
Genomic homogeneity between Mycobacterium avium subsp. avium and Mycobacterium avium subsp. paratuberculosis belies their divergent growth rates
Efflux-Inhibition bei Mycobacterium smegmatis und Mycobacterium avium
Entwicklung einer Realtime-PCR zum Nachweis von Mycobacterium avium ssp. avium und Mycobacterium avium ssp. silvaticum beim Vogel
Entwicklung einer Realtime-PCR zum Nachweis von Mycobacterium avium ssp. avium und Mycobacterium avium ssp. silvaticum beim Vogel
Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease
Correction to: Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease
Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use
Correction to: Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use
Effectiveness of Amikacin liposome inhalation suspension for refractory Mycobacterium avium complex pulmonary disease at 6 months post initiation
Qualitative Interviews Exploring Adverse Event Mitigation Strategies in Adults Receiving Amikacin Liposome Inhalation Suspension
Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment-Refractory Nontuberculous Mycobacterial Lung Disease
A comparative study of Mycobacterium avium subsp. avium and Mycobacterium avium subsp. hominissuisin experimentally infected pigs
Genomic homogeneity between Mycobacterium avium subsp. avium and Mycobacterium avium subsp. paratuberculosis belies their divergent growth rates
Efflux-Inhibition bei Mycobacterium smegmatis und Mycobacterium avium
Entwicklung einer Realtime-PCR zum Nachweis von Mycobacterium avium ssp. avium und Mycobacterium avium ssp. silvaticum beim Vogel
Entwicklung einer Realtime-PCR zum Nachweis von Mycobacterium avium ssp. avium und Mycobacterium avium ssp. silvaticum beim Vogel
Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease
Correction to: Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease
Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use
Correction to: Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use
Effectiveness of Amikacin liposome inhalation suspension for refractory Mycobacterium avium complex pulmonary disease at 6 months post initiation
Qualitative Interviews Exploring Adverse Event Mitigation Strategies in Adults Receiving Amikacin Liposome Inhalation Suspension
Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment-Refractory Nontuberculous Mycobacterial Lung Disease
A comparative study of Mycobacterium avium subsp. avium and Mycobacterium avium subsp. hominissuisin experimentally infected pigs
Genomic homogeneity between Mycobacterium avium subsp. avium and Mycobacterium avium subsp. paratuberculosis belies their divergent growth rates
Efflux-Inhibition bei Mycobacterium smegmatis und Mycobacterium avium
Entwicklung einer Realtime-PCR zum Nachweis von Mycobacterium avium ssp. avium und Mycobacterium avium ssp. silvaticum beim Vogel